1. Home
  2. IMMX vs VTSI Comparison

IMMX vs VTSI Comparison

Compare IMMX & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMX
  • VTSI
  • Stock Information
  • Founded
  • IMMX 2014
  • VTSI 1993
  • Country
  • IMMX United States
  • VTSI United States
  • Employees
  • IMMX N/A
  • VTSI N/A
  • Industry
  • IMMX Medicinal Chemicals and Botanical Products
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • IMMX Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • IMMX Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • IMMX 61.1M
  • VTSI 67.3M
  • IPO Year
  • IMMX 2021
  • VTSI N/A
  • Fundamental
  • Price
  • IMMX $2.65
  • VTSI $6.25
  • Analyst Decision
  • IMMX Strong Buy
  • VTSI Strong Buy
  • Analyst Count
  • IMMX 1
  • VTSI 1
  • Target Price
  • IMMX $7.00
  • VTSI $7.00
  • AVG Volume (30 Days)
  • IMMX 137.1K
  • VTSI 160.8K
  • Earning Date
  • IMMX 08-11-2025
  • VTSI 08-11-2025
  • Dividend Yield
  • IMMX N/A
  • VTSI N/A
  • EPS Growth
  • IMMX N/A
  • VTSI N/A
  • EPS
  • IMMX N/A
  • VTSI 0.19
  • Revenue
  • IMMX N/A
  • VTSI $26,164,645.00
  • Revenue This Year
  • IMMX N/A
  • VTSI $9.92
  • Revenue Next Year
  • IMMX N/A
  • VTSI $16.54
  • P/E Ratio
  • IMMX N/A
  • VTSI $32.87
  • Revenue Growth
  • IMMX N/A
  • VTSI N/A
  • 52 Week Low
  • IMMX $1.26
  • VTSI $3.57
  • 52 Week High
  • IMMX $3.00
  • VTSI $9.40
  • Technical
  • Relative Strength Index (RSI)
  • IMMX 61.44
  • VTSI 49.81
  • Support Level
  • IMMX $2.16
  • VTSI $6.40
  • Resistance Level
  • IMMX $2.80
  • VTSI $6.71
  • Average True Range (ATR)
  • IMMX 0.17
  • VTSI 0.43
  • MACD
  • IMMX 0.04
  • VTSI -0.07
  • Stochastic Oscillator
  • IMMX 80.00
  • VTSI 21.77

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: